TAU Scientists Develop Innovative Therapy to Prevent Deafness

Written on |

The treatment is inserted into the ear, prevents hearing loss caused by a genetic mutation.

A new study at Tel Aviv University presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear. The genetic material ‘replaces’ the genetic defect and enables the cell to continue functioning normally.

The scientists were able to prevent the gradual deterioration of hearing in mice with a genetic mutation for deafness. They maintain that this novel therapy could lead to a breakthrough in treating children born with various mutations that eventually cause deafness.

The study was led by Prof. Karen Avraham and Shahar Taiber, a student in the combined MD-PhD track, from the Department of Human Molecular Genetics and Biochemistry at the Sackler Faculty of Medicine, and the Sagol School of Neuroscience, and Prof. Jeffrey Holt from Boston Children’s Hospital and Harvard Medical School. Additional contributors included Prof. David Sprinzak from the School of Neurobiology, Biochemistry and Biophysics at the George S. Wise Faculty of Life Sciences at Tel Aviv University. The paper was published in EMBO Molecular Medicine.

Deafness is the most common sensory disability worldwide. According to the World Health Organization there are about half a billion people with hearing loss around the world today, and this figure is expected to double in the coming decades. One in every 200 children is born with a hearing impairment, and one in every 1,000 is born deaf. In about half of these cases, deafness is caused by a genetic mutation. There are currently about 100 different genes associated with hereditary deafness. 

Prof. Avraham: “In this study we focused on genetic deafness caused by a mutation in the gene SYNE4 – a rare deafness discovered by our lab several years ago in two Israeli families, and since then identified in Turkey and the UK as well. Children inheriting the defective gene from both parents are born with normal hearing, but gradually lose their hearing during childhood. This happens because the mutation causes mislocalization of cell nuclei in the hair cells inside the cochlea of the inner ear, which serve as soundwave receptors and are thus essential for hearing. This defect leads to the degeneration and eventual death of hair cells.” 

Shahar Taiber: “We implemented an innovative gene therapy technology: we created a harmless synthetic virus and used it to deliver genetic material – a normal version of the gene that is defective in both the mouse model and the affected human families. We injected the virus into the inner ear of the mice, so that it entered the hair cells and released its genetic payload. By so, we repaired the defect in the hair cells, and enabled them to mature and function normally.”

The treatment was administered soon after birth and the mice’s hearing was then monitored using both physiological and behavioral tests. Prof. Holt: “The findings are most promising: Treated mice developed normal hearing, with sensitivity almost identical to that of healthy mice who do not have the mutation”. Following the successful study, the scientists are currently developing similar therapies for other mutations that cause deafness.

Prof. Wade Chien, MD, from the NIDCD/NIH Inner Ear Gene Therapy Program and Johns Hopkins School of Medicine, who was not involved in the study, illuminates its significance: This is an important study that shows that inner ear gene therapy can be effectively applied to a mouse model of SYNE4 deafness to rescue hearing. The magnitude of hearing recovery is impressive. This study is a part of a growing body of literature showing that gene therapy can be successfully applied to mouse models of hereditary hearing loss, and it illustrates the enormous potential of gene therapy as a treatment for deafness.

The study was supported by the BSF – US-Israel Binational Science Foundation, the NIH – National Institutes of Health, the ERC – European Research Council, and the Israel Precision Medicine Partnership Program of the Israel Science Foundation.

Related posts

This Week: TAU Board of Governors Meeting 2021

October 11, 2021

Seahorses – Slow, but Fierce

October 6, 2021

Can’t Multitask Anymore?

October 6, 2021

Why Do We Squabble Over The AC?

October 5, 2021

The Immune System’s Double Agents

October 5, 2021

A House is Not a Home Without a Pet

October 4, 2021

Help A Friend Out?

September 30, 2021

Using ‘Good’ Bacteria to Fight ‘Bad’ Bacteria

September 29, 2021

Be My Guest

September 19, 2021

Recruiting ‘Fighting Cells’ to Destroy Tumors

September 14, 2021

Fighting Pollution With Seaweed

September 12, 2021

TAU Team Reverses Early Signs of Alzheimer’s

September 10, 2021

Nicotine Testing of Children Curbs Parents’ Smoking

September 5, 2021

Raising the Bar in Film

September 1, 2021

Want to Fall in Love? Step Outside in The Sun

August 31, 2021

The Silent Prophets

August 31, 2021

Recordings of the magnetic field from 9,000 years ago teach us about the magnetic field today

August 19, 2021

First 3D-bioprinting of entire active tumor

August 18, 2021

Prof. Isaac Ben-Israel Receives the IEEE Leadership Award

August 13, 2021

Where Have All the Birds Gone?

August 11, 2021

For the first time: The “God Particle” has been characterized in its decay into a pair of charm quarks

August 8, 2021

New Warning Sign for Breast Cancer

August 6, 2021

Diminishing at the Edges

August 3, 2021

This Exhibition Will Make You Sweat

August 2, 2021

He’s Bringing Plastic Back

August 2, 2021

COVID-19 Immunity Varies Among Genders and Age Groups

July 26, 2021

What to Do When Everything is Vulnerable and Under Attack

July 25, 2021

Tel Aviv Bats Have More Fun

July 22, 2021

See You at Naftali

July 22, 2021

When the stars aligned: A star in a distant galaxy blew up in a powerful explosion, solving an astronomical mystery from the 11th century

July 15, 2021

New study found differences between women and men in the level of COVID-19 antibodies

July 15, 2021

A world first: Technology that restores the sense of touch in nerves damaged as a result of amputation or injury

July 15, 2021

A New Tool for Combating Discrimination

July 15, 2021

TAU Medical Student to Swim for Israel at Summer Olympics

July 15, 2021

Digital Learning: TAU 1st in Israel According to International Ranking

July 12, 2021

New nanotech from TAU produces “healthy” electric current from the human body itself

July 9, 2021

Introducing the world’s thinnest technology – only two atoms thick

July 2, 2021

Want to Live a Long Life? Consider Investing in Your Marriage.

July 2, 2021

The Faculty of Engineering Predicts: A Greener and Safer Future

July 2, 2021

A world first: Targeted delivery of therapeutic RNAs only to cancer cells, with no harm caused to healthy cells

June 30, 2021

New Type of Prehistoric Human Discovered in Israel

June 27, 2021

Care for A Glass of Tel Aviv Air?

June 24, 2021

Leading the Global Yiddish Renaissance

June 22, 2021

Combating Antibiotic Resistance

June 22, 2021

Celebrating 20 Years of Gender Studies

June 16, 2021

TAU Alumni Fill Ranks in Israel’s New Government

June 15, 2021

Exploring New Frontiers in AI

June 14, 2021

TAU Graduates Bolster Israel’s Global Standing

June 14, 2021

We Are Part of the Problem and the Solution

June 10, 2021

Bats ‘Social Distance’ Too

June 6, 2021

Pursuing the Unknown

Copyright ©  Tel Aviv University Trust. All rights reserved.
Registered charity number 314179.